RAGE signaling contributes to neuroinflammation in infantile neuronal ceroid lipofuscinosis  by Saha, Arjun et al.
25
FEBS Letters 582 (2008) 3823–3831RAGE signaling contributes to neuroinﬂammation in infantile
neuronal ceroid lipofuscinosis
Arjun Saha, Sung-Jo Kim, Zhongjian Zhang, Yi-Ching Lee,
Chinmoy Sarkar, Pei-Chih Tsai, Anil B. Mukherjee*
Section on Developmental Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child
Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1830, United States
Received 17 September 2008; revised 6 October 2008; accepted 9 October 2008
Available online 21 October 2008
Edited by Jesus AvilaAbstract Palmitoyl-protein thioesterase-1 (PPT1) deﬁciency
causes infantile neuronal ceroid lipofuscinosis (INCL), a devas-
tating childhood neurodegenerative storage disorder. We previ-
ously reported that neuronal apoptosis in INCL is mediated by
endoplasmic reticulum-stress. ER-stress disrupts Ca2+-homeo-
stasis and stimulates the expression of Ca2+-binding proteins.
We report here that in the PPT1-deﬁcient human and mouse
brain the levels of S100B, a Ca2+-binding protein, and its recep-
tor, RAGE (receptor for advanced glycation end-products) are
elevated. We further demonstrate that activation of RAGE
signaling in astroglial cells mediates pro-inﬂammatory cytokine
production, which is inhibited by SiRNA-mediated suppression
of RAGE expression. We propose that RAGE signaling contrib-
utes to neuroinﬂammation in INCL.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Although the molecular mechanism(s) of pathogenesis in
many neurodegenerative diseases remains poorly understood,
it is increasingly evident that neuroinﬂammation contributes
to the progression of these diseases [1]. Moreover, it has been
reported that neuroinﬂammation resulting from systemic
infection may also hasten the progression of chronic neurode-
generation reviewed in [2]. In the central nervous system
(CNS), inﬂammatory processes diﬀer from those of the
systemic inﬂammation in that CNS inﬂammation involves di-
rect cellular eﬀects triggered by multiple causes and pathways
[2]. Understanding the molecular mechanism(s) of neuroin-
ﬂammation in neurodegenerative diseases may advance ourAbbreviations: INCL, infantile neuronal ceroid lipofuscinosis; PPT1,
palmitoyl-protein thioesterase-1; RAGE, receptor for advanced
glycation end products; ER, endoplasmic reticulum; CNS, central
nervous system; GROD, granular osmiophilic deposit
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doi:10.1016/j.febslet.2008.10.015knowledge of the disease pathogenesis and facilitate the devel-
opment of novel therapeutic strategies.
Neuronal ceroid lipofuscinoses (NCLs), commonly known
as Batten disease [3,4], cumulatively represent a group of the
most common (1 in 12500 live births) hereditary lysosomal
storage disorders with worldwide distribution. Although the
mutations in at least eight diﬀerent genes (CLN1–CLN8) cause
various forms of NCL, their pathological manifestations are
remarkably similar [3,4]. The infantile NCL, or INCL, is a rare
(1 in >100000 births) but the most lethal disease. INCL is
caused by mutations in the gene encoding palmitoyl-protein
thioesterase-1 (PPT1) [5], a lysosomal enzyme that catalyzes
the cleavage of the thioester linkage in polypeptides that are
palmitoylated [6]. Palmitoylation (also called S-acylation), is
a post-translational lipid-modiﬁcation of polypeptides by the
16-carbon fatty acid, palmitate [7,8]. Emerging evidence
suggests that this modiﬁcation plays critical roles in protein–
protein interaction, protein-traﬃcking, stability and mem-
brane anchorage [7,8]. While palmitoylation is critical for the
function of many proteins, the enzymatic removal of the pal-
mitate residues (de-palmitoylation) is essential for their degra-
dation and/or recycling. The lack of PPT1 activity causes
abnormal intracellular accumulation of S-acylated proteins
and peptides [9] that leads to INCL pathogenesis, although
the precise molecular mechanism(s) remain poorly understood.
The clinical features of INCL include an early loss of vision,
rapidly progressive mental deterioration, myoclonus and sei-
zures leading to a complete loss of brain activity around four
years of age. At autopsy, characteristic intracellular storage
material, known as GRODs (granular osmiophilic deposits),
are found in the neurons as well as in other cells and tissues
[10].
Recently, using postmortem brain tissues from an INCL
patient and those from the PPT1-knockout (PPT1-KO) mice
[11] that mimic INCL [12], we have demonstrated that the
PPT1-deﬁcient neurons undergo apoptosis triggered by endo-
plasmic reticulum-stress (ER-stress) [13,14]. To circumvent
the ER-stress [15,16] the cells have evolved a signaling path-
way for survival known as the unfolded protein response
(UPR) [17]. If the ER-stress is so overwhelming that the
UPR cannot resolve, the cysteine proteinases, called caspases,
are activated leading to apoptosis. ER-stress also disrupts
Ca2+-homeostasis [18,19], causing inﬂux of Ca2+. This may
stimulate the expression of Ca2+-binding proteins, some of
which are known to trigger the inﬂammatory response via
receptor-mediated pathway. Consistent with these ﬁndings,ation of European Biochemical Societies.
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neuroinﬂammation have been reported in the brain of the
PPT1-KO mice [20–22] although the molecular mechanism(s)
of neuroinﬂammation in these mice remains poorly under-
stood.
Recent reports indicate that with increasing age, the brains
of the PPT1-KO mice show widespread astrogliosis [12,23].
Moreover, S100 family of Ca2+-binding proteins via recep-
tor-mediated pathway are capable of triggering the inﬂamma-
tory response [24,25]. Indeed, cultured astroglia from the rat
[26] has been shown to express S100B, a brain-speciﬁc Ca2+-
binding protein as well as its receptor, RAGE (receptor for ad-
vanced glycation) [27]. Further, transgenic mice expressing
high levels of S100B in the brain, are highly susceptible to
developing ß-amyloid-induced neuroinﬂammation in an ani-
mal model of Alzheimers disease [28].
In the present study, we sought to determine whether in-
creased astrogliosis in INCL and in the PPT1-KO mice that
mimic INCL, trigger S100B-RAGE signaling mediating neur-
oinﬂammation. Using postmortem brain tissues from an INCL
patient and those of the PPT1-KO mice, we report here that
PPT1-deﬁciency leads to elevated levels of S100B and RAGE.
We further demonstrate that RAGE signaling mediates the
activation of Src- as well as MAP-kinases and stimulates the
activation of the transcription factor, nuclear factor-kappa B
(NF-jB). The activation of NF-jB mediates the production
of pro-inﬂammatory cytokines. Most signiﬁcantly, the block-
ing of RAGE expression by SiRNA inhibits proinﬂammatory
cytokine production in the PPT1-deﬁcient cultured astroglial
cells. We propose that the activation of the S100B-RAGE sig-
naling pathway in astroglial cells mediate proinﬂammatory
cytokine production, which at least in part contributes to neur-
oinﬂammation in INCL.2. Materials and methods
2.1. PPT1-KO mice
PPT1-KO mice (a generous gift from Dr. S.L. Hofmann, University
of Texas Southwestern Medical Center, Dallas, TX) were generated
and characterized as previously described [11]. These mice were back-
crossed to obtain the isogenic C57 genetic background in the labora-
tory of Dr. M.S. Sands (Washington University School of Medicine,
St. Louis, MO). All mice were maintained and housed in a germ-free
facility and animal procedures were carried out in accordance with
institutional guidelines after the NICHD Animal Care and Use Com-
mittee approved an animal study protocol.2.2. Postmortem INCL and normal control brain tissues
Postmortem brain tissues from an INCL patient, with clinical and
pathological diagnosis of INCL were obtained from Human Brain
and Spinal Fluid Resource Center, Los Angeles, CA. A sister of this
patient who also died of INCL was a compound heterozygote for
PPT1 mutations [del 398T in exon 4 and C451T in exon 5]; see Table
2 [in Ref. 29]. Because INCL is an autosomal recessive disease, we as-
sume that the patient was also a compound heterozygote for the same
PPT1 mutations as indicated above. Postmortem brain tissues from
age-matched normal control subjects were obtained from NICHD
Brain and Tissue Bank for Developmental Disorders, University of
Maryland School of Medicine, Baltimore, MD.2.3. Mouse astroglial cell culture
Astroglial cultures were initiated from El8 (embryo day 18) mouse
cortex using a modiﬁcation of a previously described method [30].
The cells were counted, viability tested by trypan blue dye exclusiontest and were then seeded at 5 · 106 cells/cm2 onto poly-D-lysine-
coated plates. The medium was changed on culture day 4 and every
2 days thereafter until conﬂuency was reached.
2.4. Western blot analysis and cytokine ELISA
Western blot analyses of proteins from the cytosolic and nuclear
fractions were performed as previously described [23]. Brieﬂy, the brain
tissues were homogenized in protein extracting buﬀer (50 mM Tris–
HCI, 150 mM NaCl, 0.25% SDS, 1 mM EDTA and 1% NP-40) con-
taining protease- and/or phosphatase-inhibitor cocktails (Sigma–Al-
drich). For the preparation of total lysates from cultured astroglial
cells from WT or PPT1-KO mice, cells were homogenized in Phospho-
Safe extraction reagent (EMD Biosciences) containing protease inhib-
itors (Sigma–Aldrich). Nuclear extracts from astroglial cells were
isolated using the ProteoExtract subcellular proteome extraction kit
(Calbiochem) following the manufacturers instruction. Total proteins
(30 lg) from each sample were resolved by SDS–PAGE, electro-trans-
ferred and immunodetected. Densitometric measurements of the pro-
tein bands were performed using at least three independently derived
samples. The error bars indicate standard deviation (S.D.) of the mean
(n = 3). The primary antibodies used are: anti-S100B (1:1000, a gener-
ous gift from Dr. Alexander Marks, Department of Physiology, Uni-
versity of Toronto, Toronto, Ontario, CA), anti-RAGE (1:750,
Abcam) and anti-phospho-ERK1/2 (1:5000), anti-ERK1/2 (1:1000),
anti-IkB-a (1:1000), anti-phospho-IjB-a (1:1000), anti-phospho-p38
MAP kinase (1:2000), anti-p38 MAP kinase (1:1000) and anti-p-Src
(1:2000) (Cell Signaling), anti-c-Src (1:1000), anti-NF-jB p65
(1:1000) (Santa Cruz Biotechnology) and anti-b-actin (1:5000, US Bio-
logical). The secondary antibodies used are: goat anti-rabbit IgG, don-
key anti-goat IgG and goat anti-mouse IgG (Santa Cruz
Biotechnology). Amount of proteins fromWT and PPT1-KO brain tis-
sue lysates were adjusted to a concentration of 0.5 mg/ml and used for
ELISA (Assaygate Inc.) for quantitating the released IL-1ß, IL-6,
MCP-1 and TNFa. Equal number (5 · 106 cells) of WT and PPT1-
KO astroglial cells in 10 ml media were seeded in 75 cm2 ﬂasks and cul-
tured until the 85–90% conﬂuency was reached. From these conﬂuent
astroglial cultures, conditioned media were collected for cytokine ELI-
SA (Assaygate Inc.).2.5. Fluorescence microscopy
The method for immunoﬂuorescence microscopy has been described
previously [14]. Rabbit NF-jB-anti-p65 (1:50) as the primary antibody
and goat anti-rabbit-alexaﬂuor594 (1:200) conjugated secondary anti-
body (Molecular probes) were used. Nuclei were stained with 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI, Sigma).2.6. RNA isolation and quantitative PCR analysis
Total RNA from the brains of PPT1-KO mice and their WT
littermates as well as that from cultured astroglial cells were isolated
and quantitated by real-time PCR as previously described [23]. The
primers used are presented in Supplementary Table 1. The results
were analyzed using ABI Prism Software version 1.01 (Applied Biosys-
tems). The ﬁnal data were normalized to b-actin standard and
presented as fold change in PPT1-KO mice, compared with those of
the WT mice.2.7. Si-RNA transfection
For blocking of the S100B-RAGE signaling pathway astroglial cells
were transfected with a RAGE-speciﬁc siRNA (Ambion) for reducing
RAGE expression. As a negative control, cells were transfected with a
scrambled siRNA (Ambion). SiPORT NeoFX Transfection agent
(Ambion) was used and transfection was performed following the
manufacturers protocol. Total proteins were prepared from the cells
72 h after transfection using the PhosphoSafe extraction reagent
(EMD Biosciences). Cytokine levels in the culture media were quanti-
tated by ELISA (Asssaygate Inc.).2.8. Statistical analysis
Results are expressed as the mean of at least three experi-
ments ± standard deviation (SD). Statistical analyses were performed
by Students t-test using Microsoft Excel 2002 and P < 0.05 was con-
sidered statistically signiﬁcant.
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3.1. Expression of S100B in the brain of the PPT1-KO mouse
and INCL patient
Since ER-stress disrupts Ca2+-homeostasis, we sought to
determine whether the expression of S100B in the brain of
the PPT1-deﬁcient human and mouse is elevated. Accordingly,
we ﬁrst determined the S100B-mRNA levels in the brain tis-
sues from 1, 3 and 6 month-old PPT1-KO mice and in those
of their WT littermates by quantitative RT-PCR. The results
show that compared with the WT mice, S100B-mRNA levels
in the brains of the PPT1-KO mice of all three age groupsFig. 1. Elevated expression of S100B and RAGE in the brain tissues of PP
RAGE- (D) mRNAs in the brain of 1, 3 and 6 month-old PPT1-KO mice and
from PPT1-KO mice and their WT littermates showing elevated expression of
analyses of S100B (C) and RAGE (F) in postmortem brain tissue lysates fro
Western blots represent densitometric quantitation of the protein bands. The
indicate statistical signiﬁcance: *P < 0.010; **P < 0.005. AU, arbitrary units.are markedly higher (Fig. 1A). Consistent with these results,
the Western blot analyses show that the S100B protein levels
in the PPT1-KO brains are also elevated (Fig. 1B). To deter-
mine whether these results in mice are reproducible in human
INCL brain, we analyzed the S100B protein levels in postmor-
tem brain tissues from an INCL patient and those of an age-
matched normal control by Western blot analysis. The results
show that compared with the normal control, the brain tissues
of the INCL patient contain markedly higher levels of S100B
protein (Fig. 1C). Taken together, these results show that
PPT1-deﬁcient human and mouse brains express higher levels
of S100B.T1-KO mice and their WT littermates. Expression of S100B- (A) and
in those of their WT littermates. Western blot analyses of brain lysates
S100B- (B) and RAGE (E) in the PPT1-KO mouse brain. Western blot
m a normal control and an INCL patient. The bar graphs below the
error bars indicate the standard deviation of the mean (n = 3). Asterisks
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human brain
S100B is a ligand of RAGE, and since S100B protein levels
are markedly elevated in the brain homogenates of the PPT1-
KO mice as well as in those of the INCL patient, we deter-
mined whether RAGE expression is also elevated. Accord-
ingly, we ﬁrst determined the RAGE-mRNA levels in the
brain tissues of 1, 3 and 6 month-old PPT1-KO mice and in
those of their WT littermates. The results show that compared
with the WT brains, the RAGE-mRNA levels in those of the
PPT1-KO mice are signiﬁcantly higher (Fig. 1D). Consistent
with these results, the Western blot analyses also show mark-
edly elevated levels of RAGE-protein in the brains of PPT1-
KO mice of all three age groups studied (Fig. 1E). We then
performed Western blot analyses of the postmortem brain tis-
sues from an INCL patient and those of an age-matched nor-
mal control. The results show that compared with the normal
control, the RAGE-protein levels in the INCL brain cortex
and hippocampus are signiﬁcantly higher (Fig. 1F). These re-
sults show that in the brains of PPT1-deﬁcient mouse and hu-
man there is elevated expression of RAGE.Fig. 2. Expression of S100B and RAGE in cultured astroglial cells
from PPT1-KO mice and WT littermates. Expression of S100B- (A)
and RAGE- (C) mRNAs in WT and PPT1-KO astroglial cells.
Western blot analyses of S100B (B) and RAGE (D) in WT and PPT1-
KO astroglial cells. Quantitation (bar graphs) is provided under each
Western blot. Error bars indicate standard deviation of the mean
(n = 3). Asterisks indicate statistical signiﬁcance at P < 0.005.3.3. Astroglia contribute to the elevated S100B and RAGE levels
in the PPT1-KO mouse brain
We previously reported that PPT1-deﬁcient neurons and
astroglia undergo ER-stress and it is known that ER-stress dis-
rupts Ca2+ homeostasis [13,14]. Thus, we sought to determine
whether PPT1-deﬁcient cultured astroglia express elevated lev-
els of S100B and RAGE and accounts for the observed levels
of the Ca2+-binding protein, S100B, and its receptor, RAGE,
mediating the neuroinﬂammatory response. Accordingly, we
determined the S100B- and RAGE-mRNA levels in cultured
PPT1-deﬁcient and WT astroglial cells by quantitative RT-
PCR. We also determined S100B- and RAGE-protein levels
by Western blot analyses in these cells from PPT1-KO mice
and from their WT littermates. The results show that com-
pared with the mRNA and protein levels in the WT astroglia
those derived from the PPT1-KO mice express markedly high-
er levels of S100B-mRNA (Fig. 2A) and S100B protein
(Fig. 2B). Moreover, we found that the RAGE-mRNA
(Fig. 2C) and RAGE-protein (Fig. 2D) levels are also upregu-
lated in the PPT1-deﬁcient astroglial cells. Taken together,
these results show that in the PPT1-deﬁcient astroglia the
expression of both S100B as well as RAGE is elevated and
may trigger the activation of the RAGE signaling pathway.Fig. 3. The activation of Src kinase, MEK1/2, ERK1/2 and p38 MAP-
kinases in astroglial cells from the PPT1-KO mice. (A) Western blot
analyses of WT and PPT1-KO astroglial cell extracts using anti-
phospho-Src antibody; anti-c-Src was used as the control. (B) Western
blot analyses of WT and PPT1-KO astroglial cell extracts using anti-
phospho-MEK1/2 antibody; anti-MEK1/2 was used as the control. (C)
Western blot analyses of WT and PPT1-KO astroglial cell extracts
using anti-phospho-ERK1/2 antibody; anti- ERK1/2 was used as the
control. (D) Western blot analyses of WT and PPT1-KO astroglial cell
extracts using anti-phospho-p38 antibody; anti- p38 was used as the
control. Note the elevation of Src- and MAPK- phosphorylation in
PPT1-KO astroglial cells. The error bars indicate standard deviation of
the mean (n = 3).3.4. Activation of Src tyrosine kinase in PPT1-deﬁcient cultured
astroglia
It has been reported that several receptors that lack intrinsic
tyrosine kinase activity utilize Src tyrosine kinases for signaling
to induce gene expression, cell migration and proliferation [31].
Recently, it has been shown that Src kinase is essential for
S100B mediated RAGE signaling and inﬂammation [32]. Since
we found that in the PPT1-KO brain tissues both S100B and
RAGE expressions are elevated, we sought to determine
whether the level of phosphorylated Src kinase in cultured
PPT-deﬁcient astroglia is also elevated. Accordingly, we deter-
mined the levels of phospho-Src (p-Src) in these cells from
PPT1-KO and WT mice by Western blot analysis. The results
show that compared with the WT, p-Src level is markedly ele-
vated in astroglial cells from the PPT1-KO mice (Fig. 3A).
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astroglia
Interaction of RAGE with its ligands mediates increased lev-
els of oxidative stress, cell migration, proliferation as well as
the expression of genes that are known to play critical roles
in mediating inﬂammation [33]. Moreover, RAGE-mediatedFig. 4. Increased phosphorylation of IkBa and nuclear translocation of NF-j
astroglial cell extracts from PPT1-KO and WT littermates using phospho-Ik
astroglial cells. (B) Western blot analyses of nuclear extracts from PPT1-KO
used as the loading standard for the nuclear protein fractions. (C) Activation
The cells were processed for immunoﬂuorescence staining detecting sub-cellul
PPT1-KO (Right panels). Nuclei were stained with DAPI (blue; middle panel
observed. Scale bars, 100 lm. The error bars indicate standard deviation of t
ﬁgure legend, the reader is referred to the web version of this article.)signaling can stimulate multiple pathways, including MAPK
[34]. Since we previously reported that elevated levels of oxida-
tive stress is readily detectable in the brain of the PPT1-KO
mice, we sought to determine whether elevated expression of
S100B and RAGE in the PPT1-KO brain triggers RAGE sig-
naling pathways leading to MAPK activation. Accordingly, weB p65 subunit in PPT1-KO astroglial cells. (A) Western blot analyses of
Ba antibody showing increased phosphorylation of IkBa in PPT1-KO
and WT astroglial cells using NF-kB p65 antibody. Histone H4 was
of NF-jB in cultured astroglial cells from the PPT1-KO and WT mice.
ar localization of NF-jB subunit p65 (red) in the WT (Left panels) and
). Increased immunoreactivity for p65 in the nuclei of KO cells was also
he mean (n = 3). (For interpretation of the references to colour in this
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2), phosphorylated-ERK1/2 (p-ERK1/2) and phosphory-
lated-p38 (p-p38) in cultured astroglial cells from the PPT1-
KO mice and in their WT littermates. The results show that
the levels of p-MEK1/2 (Fig. 3B), p-ERK1/2 (Fig. 3C) and
p-p38 (Fig. 3D) are signiﬁcantly elevated in the PPT1-deﬁcient
astroglial cells.
3.6. Activation of NF-jB in the PPT1-deﬁcient cultured
astroglial cells
The interaction of RAGE with S100 proteins leads to
inﬂammation and RAGE is a potential drug target for control-
ling inﬂammation [35]. Since it has been reported that the acti-
vation of NF-jB plays critical roles in generating the
inﬂammatory response, we investigated whether this pathway
might be involved in causing neuroinﬂammation in INCL. It
has been reported that rapid phosphorylation and degradation
of IjBa and subsequent release and translocation of NF-jB
(p65) from the cytosol to the nucleus precede the inﬂammatory
response. Accordingly, we determined the levels of phosphor-
ylated-IkBa (p-IkBa) in the cytosol and NF-jB (p65) in the
nuclear fraction of cultured astroglia from the PPT1-KO mice
and their WT littermates. The results show that compared with
the WT littermates, the levels of p-IkBa in the cytosolic frac-
tion (Fig. 4A) and NF-jB (p65) in the nuclear fraction
(Fig. 4B) of the PPT1-deﬁcient astroglia are markedly higher.
Further evidence for NF-jB activation was obtained by cyto-
chemical analysis of the cultured astroglial cells from the
PPT1-KO mice and their WT littermates. The results show
that compared with WT cells, the nuclear translocation of
the p65 subunit of NF-jB in the PPT1-deﬁcient cells is appre-
ciably elevated (Fig. 4C).Fig. 5. Elevated secretion of IL-1ß, IL-6, MCP-1 and TNFa in PPT1-KO mo
from astroglial cell cultures. The results are expressed as the mean (n = 3) ±3.7. Expression of pro-inﬂammatory mediators in the brain of
the PPT1-deﬁcient mice and in cultured astroglia
Because the activation of NF-jB mediates increased expres-
sion of pro-inﬂammatory cytokines, we analyzed the levels of
four key cytokines, IL-1ß, IL-6, MCP-1 and TNF-a, in 6
month-old PPT1-KO mice and their WT littermates. Six
month-old PPT1-KO mice were chosen because at this age
astrogliosis is at a very high level in the PPT1-KO mouse
brain. We also analyzed the levels of the cytokines in the con-
ditioned media from WT and PPT1-deﬁcient astroglia cultures
by ELISA. Our results show that compared with the levels of
these cytokines in the WT mouse brain and in WT astroglial
cell culture media (Fig. 5A–D, open bars), those in the
PPT1-KO littermates and culture media from the PPT1-deﬁ-
cient astroglia are markedly elevated (Fig. 5A–D, solid bars).
These results are consonant with the high levels of RAGE
and S100B expression we found in the brain tissues of the
PPT1-KO mice as well as in those of the INCL patient. Taken
together, these results raise the possibility that RAGE signal-
ing mediates the production of proinﬂammatory cytokines in
astroglia, which in turn cause neuroinﬂammation in INCL.
3.8. Suppression of RAGE expression inhibits proinﬂammatory
mediator production
To determine whether the production of proinﬂammatory
cytokines is mediated via RAGE signaling, we suppressed
RAGE expression in cultured astroglial cells derived from
PPT1-KO mice and measured the cytokine levels before and
after the suppression of RAGE. We used RAGE-speciﬁc siR-
NA to suppress RAGE expression and transfection of the cells
with a scrambled siRNA served as controls. We measured the
levels of RAGE, phosphorylated as well as non-phosphory-use brain extract as well as in those of the PPT1-KO conditioned media
S.D.
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Our results show that treatment of the PPT1-deﬁcient cells
with RAGE-speciﬁc siRNA not only reduced the level of
RAGE but also the levels of p-ERK1/2, p-Src and p-p38
(Fig. 6). We then sought to determine the eﬀects of suppressing
RAGE expression on the production of proinﬂammatory
mediators. Accordingly, we quantitated the levels of IL-1b,
IL-6, MCP-1 and TNF-a in the culture media of astroglial cells
that are either mock transfected, scrambled Si-RNA transfec-
ted or transfected with RAGE-speciﬁc SiRNA. The results
show that suppression of RAGE expression occurred only
when the cells were transfected with RAGE-speciﬁc SiRNA,
which also inhibited the production of IL-1 ß, IL-6, MCP-1
and TNF-a (Fig. 7). Taken together, our results suggest that
proinﬂammatory cytokine production by PPT1-deﬁcient
astroglial cells is mediated by RAGE signaling and most likely
a contributing factor in mediating neuroinﬂammation in
INCL.4. Discussion
In this study, we sought to determine the molecular mecha-
nism(s) of neuroinﬂammation in INCL, a devastating neurode-Fig. 6. Eﬀect of a RAGE-speciﬁc siRNA transfection of PPT1-
deﬁcient astroglial cells to suppress RAGE expression. Both WT and
PPT1-KO astroglial cells were transfected with siRNAs or with a
scrambled siRNA (Ambion, USA) as control. Western blot analyses
were performed using anti-RAGE, -ß-Actin, -pSrc, c-Src, -pERK1/2,
ERK1/2, -pP38 or -P38 antibodies.
Fig. 7. Eﬀect of RAGE-SiRNA on the expression of pro-inﬂamma-
tory cytokines. Note that suppression of RAGE expression by SiRNA
markedly decreased the cytokine production.generative storage disorder in children that has no eﬀective
treatment. We have demonstrated that in the brain tissues of
both the INCL patient and in those of the PPT1-KO mice that
mimic INCL, the expression of S100B, a brain-speciﬁc Ca2+-
binding protein, and its receptor, RAGE, are appreciably high-
er than that if normal controls. We further demonstrated that
in the brain of the PPT1-KO mice signiﬁcantly higher levels of
the following cytokines, IL-1b, IL-6, MCP-1 and TNF-a, are
readily detectable. These cytokines are well-known mediators
of inﬂammation. Moreover, our results show that the produc-
tion of these mediators requires RAGE signaling as the inhibi-
tion of RAGE expression markedly inhibited the production
of the proinﬂammatory cytokines. Thus, our results show that
increased S100B in conjunction with elevated levels of RAGE
expression may trigger neuroinﬂammation in INCL.
In several brain disorders including traumatic brain injury,
the concentrations of S100B in the serum and cerebrospinal
ﬂuid tend to increase [36]. We previously reported that in
INCL and in the PPT1-KO mice neuronal apoptosis, at least
in part, is mediated by ER- [13] and oxidative [37]-stresses.
ER-stress disrupts Ca2+-homeostasis [18] and excessive Ca2+
release in the cytosol due to ER-stress may stimulate the pro-
duction of S100B, which also augments the expression of its
receptor, RAGE. The interaction of S100B with RAGE acti-
vates signaling pathways leading to NF-jB activation, which
in turn induces the expression of the genes that encode proin-
3830 A. Saha et al. / FEBS Letters 582 (2008) 3823–3831ﬂammatory cytokines [38]. Consistent with the results of our
present study, it has been reported that NF-jB may be a sen-
sor of oxidative stress [reviewed in 39]. Indeed, increased pro-
duction of reactive oxygen species (ROS), as observed in the
brain of PPT1-KO mice [14,37] has been reported and it has
been shown that ROS production is associated with up regula-
tion of activated NF-jB [40]. Moreover, it has been demon-
strated that the activation of NF-jB in certain circumstances
is coupled with the activation of the Src- [32] and MAP-kinases
[41,42]. Thus, the results of our present investigation are con-
sistent with our previous demonstration that PPT1-deﬁciency
leads to ER- and oxidative-stresses [13,37]. To our knowledge,
this is the ﬁrst report demonstrating that S100B-RAGE
signaling is instrumental in the elevated production of pro-
inﬂammatory cytokines, which most likely contributes to neur-
oinﬂammation in INCL.
It is increasingly evident that neuroinﬂammation contributes
to the progression of neurodegeneration. Recently, it has been
proposed that RAGE may be a potential target for amyloid
beta-mediated cellular perturbation in Alzheimers disease
[43]. One of the major complications in neurodegenerative dis-
eases is the activation and brain inﬁltration of astroglia. The
activation of astroglia has been reported in neurodegenerative
diseases such as Sandhoﬀs disease [44], in animal models of
lysosomal storage disorders such as mucopolysaccharidoses I
and IIIB [45] and in INCL [12,23]. In the central nervous sys-
tem, astroglial cells represent the immune cells that play criti-
cal roles in mediating neuroinﬂammation [43]. The results of
our present investigation demonstrate that these immune cells
in the brain of the PPT1-KO mice, which mimic INCL, are
capable of secreting proinﬂammatory cytokines via RAGE sig-
naling pathway and most likely stimulate the neuroinﬂamma-
tory response. This raises the possibility that suppressing
RAGE expression, signaling or blocking the interaction of
S100B with RAGE may have beneﬁcial eﬀects in ameliorating
neuroinﬂammation in INCL.
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